PEOPLE - British Heart Foundation makes appointment:
This article was originally published in Clinica
The British Heart Foundation has appointed Peter Weissberg as medical director, effective at the end of 2004. He succeeds Sir Charles George, who is joining the British Medical Association as president after a 5-year tenure with the BHF. He will work in a dual capacity until the end of the year. Professor Weissberg has served with the BHF since 1994, when he was elected chair of cardiovascular medicine. His research has focused on the cell and molecular biology of atherosclerosis, and in recent years, he has been developing new clinical imaging techniques to study atherosclerosis in patients with cerebrovascular disease.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.